Comparison of pre- and peri operative immunonutrition to standard formula in patients undergoing surgical resection of oesophageal cancer

Not Applicable

Recruiting

• Conditions: Patients undergoing oesophagectomy for cancer resection; Surgery - Other surgery; Cancer - Oesophageal (gullet)

• Registration Number: ACTRN12611000178943
• Lead Sponsor: Professor Glyn Jamieson

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 232

Inclusion Criteria

Histologically proven neoplasm of the oesophagus or gastro oesophageal junction

Patients scheduled for oesophagectomy or oesophago-gastrectomy and insertion of a feeding jejunostomy

Exclusion Criteria

Patients requiring parenteral nutrition

Pregnancy

Cognitive or other limitations preventing patient from being able to provide informed consent

Taking fish oil or fish oil capsules, flaxseed oil or flaxseed capsules, cod liver oil or cod liver capsules or consuming products enriched with immunonutrients eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arginine (e.g. ProSure or Resource Support or Forticare) within 2 weeks of the proposed surgery or not willing to cease these products at least 2 weeks prior to the proposed surgery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified